P Raffo

642 total citations
20 papers, 538 citations indexed

About

P Raffo is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, P Raffo has authored 20 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Oncology. Recurrent topics in P Raffo's work include Retinoids in leukemia and cellular processes (13 papers), Estrogen and related hormone effects (9 papers) and Antioxidant Activity and Oxidative Stress (6 papers). P Raffo is often cited by papers focused on Retinoids in leukemia and cellular processes (13 papers), Estrogen and related hormone effects (9 papers) and Antioxidant Activity and Oxidative Stress (6 papers). P Raffo collaborates with scholars based in Italy, Switzerland and United Kingdom. P Raffo's co-authors include Raffaella Palumbo, Carlo Tacchetti, Ranieri Cancedda, Sara Tavella, Patrizio Castagnola, S. Toma, Giuseppe Dastoli, Salvatore Toma, L Isnardi and Werner Bollag and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

P Raffo

19 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Raffo Italy 12 317 133 121 104 83 20 538
Andrew Yen United States 14 365 1.2× 52 0.4× 103 0.9× 76 0.7× 36 0.4× 25 755
L. Adam United States 9 279 0.9× 69 0.5× 213 1.8× 27 0.3× 102 1.2× 10 544
Irena Klima Switzerland 11 233 0.7× 38 0.3× 157 1.3× 140 1.3× 114 1.4× 17 485
Mateusz Koptyra United States 15 424 1.3× 32 0.2× 157 1.3× 182 1.8× 46 0.6× 35 958
Pierre Lao-Sirieix United Kingdom 14 279 0.9× 54 0.4× 156 1.3× 101 1.0× 255 3.1× 19 821
Huifang Xu United Kingdom 10 189 0.6× 35 0.3× 122 1.0× 43 0.4× 32 0.4× 11 528
Paola Sterpetti Italy 9 378 1.2× 49 0.4× 121 1.0× 14 0.1× 78 0.9× 11 646
Maria Grazia Cipolleschi Italy 14 178 0.6× 25 0.2× 72 0.6× 19 0.2× 31 0.4× 21 436
Yasumichi Kuwahara Japan 17 472 1.5× 30 0.2× 131 1.1× 35 0.3× 119 1.4× 42 687
Valentina Guarino Italy 10 351 1.1× 75 0.6× 364 3.0× 67 0.6× 50 0.6× 14 888

Countries citing papers authored by P Raffo

Since Specialization
Citations

This map shows the geographic impact of P Raffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Raffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Raffo more than expected).

Fields of papers citing papers by P Raffo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Raffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Raffo. The network helps show where P Raffo may publish in the future.

Co-authorship network of co-authors of P Raffo

This figure shows the co-authorship network connecting the top 25 collaborators of P Raffo. A scholar is included among the top collaborators of P Raffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Raffo. P Raffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clerici, Carlo, Danilo Castellani, Giuseppe Russo, et al.. (2004). Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma.. PubMed. 24(2C). 1255–60. 16 indexed citations
2.
Emionite, Laura, et al.. (2003). Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.. PubMed. 23(1A). 13–9. 10 indexed citations
3.
Falanga, Anna, S. Toma, Marina Marchetti, et al.. (2002). Effect of all‐trans‐Retinoic acid on the hypercoagulable state of patients with breast cancer. American Journal of Hematology. 70(1). 9–15. 12 indexed citations
4.
Toma, S., P Raffo, Guido Nicolò, et al.. (2000). Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.. International Journal of Oncology. 17(5). 991–1000. 26 indexed citations
5.
Isnardi, L, et al.. (2000). Different effects of the treatment with AGN 193836 and 9-cis-retinoic acid in breast cancer cells.. PubMed. 19(4B). 3083–92. 1 indexed citations
6.
Raffo, P, et al.. (2000). Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines.. PubMed. 20(3A). 1535–43. 45 indexed citations
7.
Toma, S., P Raffo, L Isnardi, & Raffaella Palumbo. (1999). Retinoids in lung cancer chemoprevention and treatment. Annals of Oncology. 10. S95–S102. 20 indexed citations
8.
Palumbo, Raffaella, Giovanni Bertero, P Raffo, et al.. (1999). Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study. European Journal of Cancer. 35(1). 66–72. 23 indexed citations
9.
Toma, Salvatore, L Isnardi, P Raffo, et al.. (1998). RARα antagonist RO 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines. International Journal of Cancer. 78(1). 86–94. 40 indexed citations
10.
Toma, Salvatore, L Isnardi, P Raffo, et al.. (1997). Effects of ALL-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction. International Journal of Cancer. 70(5). 619–627. 102 indexed citations
11.
Toma, Salvatore, et al.. (1997). Synergistic effect between doxorubicin and a low dose of all-trans-retinoic acid in MCF-7 breast cancer cell line. Cancer Letters. 116(1). 103–110. 13 indexed citations
12.
Toma, S., Mario Airoldi, Raffaella Palumbo, P Raffo, & C. Bumma. (1997). Combination of alpha-interferon 2a (α-IFN 2a) and 13-CIS-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN). International Journal of Cancer. 70(4). 491–493. 3 indexed citations
13.
Palumbo, Raffaella, Sebastian T. Palmeri, Mauro Antimi, et al.. (1997). Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Annals of Oncology. 8(11). 1159–1162. 51 indexed citations
14.
Palumbo, Raffaella, et al.. (1997). Paclitaxel (taxol) in pretreated, relapsed and/or metastatic adult soft tissue sarcomas (STS). Oncology Reports. 4(1). 127–30. 1 indexed citations
15.
Toma, S., P Raffo, L Isnardi, et al.. (1997). Associations of retinoids, tamoxifen and alpha-interferon 2a in human breast cancer. International Journal of Oncology. 10(3). 597–607. 3 indexed citations
16.
Castagnola, Patrizio, Sara Tavella, P Raffo, et al.. (1996). Retinoic acid-induced heparin binding (RIHB, chicken midkine) factor expression by cultured chondrocytes is strongly enhanced by ascorbic acid.. PubMed. 69(4). 387–91. 2 indexed citations
17.
Toma, S., Nicola Ragni, P Raffo, et al.. (1996). Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study.. PubMed. 16(2). 931–6. 14 indexed citations
18.
Toma, S., et al.. (1994). 13-cis-retinoic acid, beta-carotene and other anti-oxidant agents in chemoprevention and therapy of head and neck cancer. European Journal of Cancer Prevention. 3(4). 374–376.
19.
Tavella, Sara, P Raffo, Carlo Tacchetti, Ranieri Cancedda, & Patrizio Castagnola. (1994). N-CAM and N-Cadherin Expression during in Vitro Chondrogenesis. Experimental Cell Research. 215(2). 354–362. 155 indexed citations
20.
Raffo, P, et al.. (1951). [Hemolytic anemia caused by spider bite].. PubMed. 79(4). 263–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Yen Breakdown of academic impact, for papers by L. Adam Breakdown of academic impact, for papers by Irena Klima Breakdown of academic impact, for papers by Mateusz Koptyra Breakdown of academic impact, for papers by Pierre Lao-Sirieix Breakdown of academic impact, for papers by Huifang Xu Breakdown of academic impact, for papers by Paola Sterpetti Breakdown of academic impact, for papers by Maria Grazia Cipolleschi Breakdown of academic impact, for papers by Yasumichi Kuwahara Breakdown of academic impact, for papers by Valentina Guarino
Rankless by CCL
2026